Page last updated: 2024-08-21

indican and Bone Loss, Osteoclastic

indican has been researched along with Bone Loss, Osteoclastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brazier, M; Godin, C; Kamel, S; Louvet, L; Massy, ZA; Mentaverri, R; Mozar, A1
Fujieda, A; Fukagawa, M; Hosokawa, A; Iwasaki, Y; Motojima, M; Nii-Kono, T; Uchida, M; Yamato, H1

Reviews

1 review(s) available for indican and Bone Loss, Osteoclastic

ArticleYear
Uremic toxin and bone metabolism.
    Journal of bone and mineral metabolism, 2006, Volume: 24, Issue:2

    Topics: Aluminum; Bone and Bones; Bone Diseases; Bone Resorption; Chronic Kidney Disease-Mineral and Bone Disorder; Glycoproteins; Humans; Indican; Osteitis Fibrosa Cystica; Osteoprotegerin; Parathyroid Hormone; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Toxins, Biological; Uremia; Vitamin D

2006

Other Studies

1 other study(ies) available for indican and Bone Loss, Osteoclastic

ArticleYear
Indoxyl sulphate inhibits osteoclast differentiation and function.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Volume: 27, Issue:6

    Topics: Animals; Bone Resorption; Cell Differentiation; Cells, Cultured; Collagen Type I; Humans; Indican; Leukocytes, Mononuclear; Macrophages; MAP Kinase Kinase 4; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocytes; Osteoclasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Transcription Factor AP-1

2012